VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

10490	Companies
221167	Keywords
150415	Articles
116981	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 02/05/2025 at 07:00, 1 year 3 months ago

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Valneva receives marketing authorization in the UK for the world's first chikungunya vaccine, IXCHIQ®. Single-dose vaccine for individuals 18+ provides rapid and strong immune response

UK Valneva MHRA Chikungunya Vaccine IXCHIQ®
BRIEF

published on 12/05/2024 at 07:35, 1 year 5 months ago

Valneva Reports Share and Voting Rights as of November 30, 2024

Euronext Paris Share Capital Voting Rights Valneva Double Voting
PRESS RELEASE

published on 12/05/2024 at 07:30, 1 year 5 months ago

VALNEVA - Declaration of shares and voting rights: November 30, 2024
VALNEVA declares transfer of 1,000 shares into bearer form with double voting rights on November 26, 2024. Total voting rights: 178,371,727

Euronext Paris Voting Rights Shares Stock Market Valneva
BRIEF

published on 12/04/2024 at 10:02, 1 year 5 months ago

Polar Capital reduces its stake in VALNEVA SE

Voting Rights Actions Valneva SE Threshold Crossing Polar Capital
BRIEF

published on 12/04/2024 at 07:05, 1 year 5 months ago

Valneva Publishes Findings on Chikungunya Impact in British Medical Journal

Climate Change Chikungunya Health Impact Economic Burden Global Study
PRESS RELEASE

published on 12/04/2024 at 07:00, 1 year 5 months ago

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Valneva SE announces the publication of an article on the global health and economic burden of chikungunya in The British Medical Journal, revealing higher disease burden and substantial costs

Valneva SE Global Health Chikungunya Economic Burden British Medical Journal
BRIEF

published on 11/26/2024 at 17:50, 1 year 6 months ago

Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion

Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence
PRESS RELEASE

published on 11/26/2024 at 17:45, 1 year 6 months ago

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
Valneva submits label extension application to U.S. FDA for its chikungunya vaccine, IXCHIQ®, to potentially include adolescents aged 12 to 17 years and two-year antibody persistence data

FDA Valneva Chikungunya Vaccine IXCHIQ Label Extension Application
BRIEF

published on 10/10/2024 at 07:05, 1 year 7 months ago

Valneva presents its outlook at an investor day in New York

Investors Growth Valneva Vaccines Lyme
PRESS RELEASE

published on 10/10/2024 at 07:00, 1 year 7 months ago

Valneva Hosts Investor Day in New York City
Valneva SE is hosting an investor day in New York City to discuss key value drivers, including Lyme disease vaccine, commercial vaccines, and R&D pipeline. Hybrid event with webcast and Q&A sessions

Investor Day Valneva SE Lyme Disease Vaccine R&D Pipeline Commercial Vaccines

Accesswire

Published on 06/02/2026 at 19:45, 51 minutes ago

Announces Plans to Repurchase Common Shares
Published on 06/02/2026 at 19:40, 56 minutes ago

Taranis Outlines Four High-Priority Targets Around Thor and Thirty Prospects and Old Mines Located within 6,470 Ha Property
Published on 06/02/2026 at 16:15, 4 hours 21 minutes ago

Vulcan Minerals Inc. - Drilling to Resume at Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 06/02/2026 at 15:05, 5 hours 31 minutes ago

Apex Announces Closing of Brokered LIFE Offering for Gross Proceeds of $15,000,500
Published on 06/02/2026 at 15:04, 5 hours 32 minutes ago

LQR House Inc. Closes Additional 30% Interest in Fusion Five Continents Securities, Crossing Majority Ownership of an AI-Powered Cross-Border Brokerage Built on USDT Settlement Infrastructure

View all ACCESSWIRE

EQS Group

Published on 06/02/2026 at 19:50, 45 minutes ago

Recorded Future Announces Strategic Partnership with Wipro to Deliver AI-Powered Threat Intelligence at Global Enterprise Scale
Published on 06/02/2026 at 19:41, 54 minutes ago

Avolta prices EUR 400 million of Senior Notes
Published on 06/02/2026 at 19:28, 1 hour 7 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/02/2026 at 18:24, 2 hours 12 minutes ago

Holding(s) in Company
Published on 06/02/2026 at 17:45, 2 hours 51 minutes ago

LightOn launches a sovereign SaaS offering to simplify enterprise integration of document AI.

Les Echos

Published on 06/02/2026 at 18:03, 2 hours 32 minutes ago

Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 2 hours 54 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 2 hours 56 minutes ago

Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 12 hours 36 minutes ago

EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 13 hours 6 minutes ago

OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest

View all LES ECHOS COMFI WIRE